Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT).

MLA

Ashida, Hirokazu, et al. “Imaging Predictor of Ophthalmic Involvement in Maxillary Sinus Cancer during Super Selective Intra-Arterial Cisplatin Infusion and Concomitant Radiotherapy (RADPLAT).” Head & Face Medicine, vol. 17, no. 1, Aug. 2021, p. 34. EBSCOhost, https://doi.org/10.1186/s13005-021-00285-z.

APA

Ashida, H., Igarashi, T., Nozawa, Y., Munetomo, Y., Higuchi, T., Yamauchi, H., Baba, A., Abe, Y., Shimura, E., Kessoku, H., Nishiya, Y., Kojima, H., & Ojiri, H. (2021). Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT). Head & Face Medicine, 17(1), 34. https://doi.org/10.1186/s13005-021-00285-z

Chicago

Ashida, Hirokazu, Takao Igarashi, Yosuke Nozawa, Yohei Munetomo, Takahiro Higuchi, Hideomi Yamauchi, Akira Baba, et al. 2021. “Imaging Predictor of Ophthalmic Involvement in Maxillary Sinus Cancer during Super Selective Intra-Arterial Cisplatin Infusion and Concomitant Radiotherapy (RADPLAT).” Head & Face Medicine 17 (1): 34. doi:10.1186/s13005-021-00285-z.